Cargando…
Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875741/ https://www.ncbi.nlm.nih.gov/pubmed/20523873 http://dx.doi.org/10.4103/0253-7613.56070 |
| _version_ | 1782181634894725120 |
|---|---|
| author | Mahajan, Rajiv |
| author_facet | Mahajan, Rajiv |
| author_sort | Mahajan, Rajiv |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2875741 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2009 |
| publisher | Medknow Publications |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-28757412010-06-03 Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes Mahajan, Rajiv Indian J Pharmacol Short Communication Medknow Publications 2009-08 /pmc/articles/PMC2875741/ /pubmed/20523873 http://dx.doi.org/10.4103/0253-7613.56070 Text en © Indian Journal of Pharmacology http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Short Communication Mahajan, Rajiv Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes |
| title | Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes |
| title_full | Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes |
| title_fullStr | Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes |
| title_full_unstemmed | Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes |
| title_short | Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes |
| title_sort | bromocriptine mesylate: fda-approved novel treatment for type-2 diabetes |
| topic | Short Communication |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875741/ https://www.ncbi.nlm.nih.gov/pubmed/20523873 http://dx.doi.org/10.4103/0253-7613.56070 |
| work_keys_str_mv | AT mahajanrajiv bromocriptinemesylatefdaapprovednoveltreatmentfortype2diabetes |